Annual EBIT:
-$156.32M+$340.59M(+68.54%)Summary
- As of today, APLS annual earnings before interest & taxes is -$156.32 million, with the most recent change of +$340.59 million (+68.54%) on December 31, 2024.
- During the last 3 years, APLS annual EBIT has risen by +$576.44 million (+78.67%).
- APLS annual EBIT is now -3779.42% below its all-time high of -$4.03 million, reached on December 31, 2013.
Performance
APLS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$33.29M+$50.04M(+60.05%)Summary
- As of today, APLS quarterly earnings before interest & taxes is -$33.29 million, with the most recent change of +$50.04 million (+60.05%) on June 30, 2025.
- Over the past year, APLS quarterly EBIT has dropped by -$3.84 million (-13.05%).
- APLS quarterly EBIT is now -125.58% below its all-time high of $130.12 million, reached on December 31, 2020.
Performance
APLS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$190.06M-$3.84M(-2.06%)Summary
- As of today, APLS TTM earnings before interest & taxes is -$190.06 million, with the most recent change of -$3.84 million (-2.06%) on June 30, 2025.
- Over the past year, APLS TTM EBIT has increased by +$123.07 million (+39.30%).
- APLS TTM EBIT is now -7022.01% below its all-time high of -$2.67 million, reached on September 30, 2014.
Performance
APLS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APLS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +68.5% | -13.1% | +39.3% |
| 3Y3 Years | +78.7% | +77.6% | +61.6% |
| 5Y5 Years | +47.8% | +71.2% | +57.7% |
APLS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +78.7% | -27.2% | +81.0% | -15.2% | +70.3% |
| 5Y | 5-Year | at high | +78.7% | -125.6% | +82.9% | -15.2% | +70.3% |
| All-Time | All-Time | -3779.4% | +78.7% | -125.6% | +82.9% | -7022.0% | +70.3% |
APLS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$33.29M(+60.1%) | -$190.06M(-2.1%) |
| Mar 2025 | - | -$83.33M(-218.5%) | -$186.22M(-12.9%) |
| Dec 2024 | -$156.32M(+68.5%) | -$26.16M(+44.7%) | -$164.98M(+26.1%) |
| Sep 2024 | - | -$47.28M(-60.6%) | -$223.33M(+28.7%) |
| Jun 2024 | - | -$29.44M(+52.6%) | -$313.13M(+22.5%) |
| Mar 2024 | - | -$62.09M(+26.5%) | -$404.13M(+21.9%) |
| Dec 2023 | -$496.92M(+19.7%) | -$84.52M(+38.3%) | -$517.12M(+13.3%) |
| Sep 2023 | - | -$137.08M(-13.8%) | -$596.66M(+2.6%) |
| Jun 2023 | - | -$120.44M(+31.2%) | -$612.51M(+4.4%) |
| Mar 2023 | - | -$175.08M(-6.7%) | -$640.70M(-7.8%) |
| Dec 2022 | -$618.88M(+15.5%) | -$164.05M(-7.3%) | -$594.61M(-14.4%) |
| Sep 2022 | - | -$152.94M(-2.9%) | -$519.96M(-5.0%) |
| Jun 2022 | - | -$148.62M(-15.2%) | -$495.01M(+8.4%) |
| Mar 2022 | - | -$129.00M(-44.3%) | -$540.68M(-0.8%) |
| Dec 2021 | -$732.76M(-134.0%) | -$89.40M(+30.2%) | -$536.27M(-69.3%) |
| Sep 2021 | - | -$128.00M(+34.1%) | -$316.75M(+0.5%) |
| Jun 2021 | - | -$194.29M(-55.9%) | -$318.31M(-32.9%) |
| Mar 2021 | - | -$124.59M(-195.8%) | -$239.53M(-12.1%) |
| Dec 2020 | -$313.09M | $130.12M(+200.4%) | -$213.72M(+52.5%) |
| Sep 2020 | - | -$129.55M(-12.2%) | -$449.79M(-15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$115.51M(-16.9%) | -$390.18M(-15.4%) |
| Mar 2020 | - | -$98.79M(+6.8%) | -$338.15M(-17.4%) |
| Dec 2019 | -$299.42M(-139.6%) | -$105.94M(-51.5%) | -$288.02M(-31.4%) |
| Sep 2019 | - | -$69.95M(-10.2%) | -$219.27M(-18.4%) |
| Jun 2019 | - | -$63.48M(-30.5%) | -$185.13M(-19.3%) |
| Mar 2019 | - | -$48.65M(-30.8%) | -$155.14M(-21.3%) |
| Dec 2018 | -$124.99M(-146.9%) | -$37.20M(-3.9%) | -$127.92M(-17.7%) |
| Sep 2018 | - | -$35.80M(-6.9%) | -$108.72M(-28.7%) |
| Jun 2018 | - | -$33.49M(-56.2%) | -$84.51M(-33.8%) |
| Mar 2018 | - | -$21.44M(-19.1%) | -$63.15M(-24.4%) |
| Dec 2017 | -$50.63M(-86.7%) | -$17.99M(-55.3%) | -$50.77M(-29.2%) |
| Sep 2017 | - | -$11.59M(+4.5%) | -$39.30M(-12.5%) |
| Jun 2017 | - | -$12.13M(-34.0%) | -$34.94M(-53.2%) |
| Mar 2017 | - | -$9.05M(-38.8%) | -$22.81M(-65.8%) |
| Dec 2016 | -$27.12M(-35.0%) | -$6.52M(+9.9%) | -$13.76M(+3.1%) |
| Sep 2016 | - | -$7.23M(-3.9%) | -$14.20M(-17.1%) |
| Dec 2015 | -$20.09M(-77.9%) | -$6.96M(-35.0%) | -$12.13M(-50.1%) |
| Sep 2015 | - | -$5.16M(-76.9%) | -$8.08M(-44.6%) |
| Dec 2014 | -$11.29M(-180.3%) | -$2.92M(-9.3%) | -$5.59M(-109.3%) |
| Sep 2014 | - | -$2.67M | -$2.67M |
| Dec 2013 | -$4.03M | - | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of APLS is -$156.32M
What is the all-time high annual EBIT for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$4.03M
What is Apellis Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, APLS annual earnings before interest & taxes has changed by +$340.59M (+68.54%)
What is Apellis Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of APLS is -$33.29M
What is the all-time high quarterly EBIT for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $130.12M
What is Apellis Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, APLS quarterly earnings before interest & taxes has changed by -$3.84M (-13.05%)
What is Apellis Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of APLS is -$190.06M
What is the all-time high TTM EBIT for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$2.67M
What is Apellis Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, APLS TTM earnings before interest & taxes has changed by +$123.07M (+39.30%)